Digitisation | April 10, 2026
Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
The leading hospital chain appoints Lokesh Taridalu Shivakumar as Facility Director for Yeshwanthapur hospital
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
Subscribe To Our Newsletter & Stay Updated
